News

New Targets for Clinical Trials in the European Union

November 18, 2025

The European Union aims to become the most attractive destination for clinical research.

Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation

November 17, 2025

Mechanistic models and hypothesis-driven strategies generate optimized efficient solutions for drug development, says Catalent’s Nathan Bennette at AAPS PharmSci 360.

How Therapeutic and Analytical Advancements Help Drug Substance Testing Evolve

November 17, 2025

Quality, stability, sustainability, and the increased and thoughtful integration of artificial intelligence are foremost in the minds of those on the leading edge of testing trends.

Implications on SMA Care of High-Dose Nusinersen

November 17, 2025

CHMP supports an enhanced nusinersen regimen, according to Biogen, indicating possible SMA treatment shifts and international regulatory decisions.

At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development

November 14, 2025

Corey Bloom of Lonza outlines major points from his AAPS presentation, from drug delivery technology selection to the importance of CDMO partnerships.

PharmTech Weekly News Roundup — Week of November 10, 2025

November 14, 2025

Accelerated drug development insights using AI/digital twins, advanced bioanalysis, targeted delivery, and optimized formulation stability models.

UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report

November 14, 2025

To prevent catastrophic loss of expertise and investment, government and academic leaders say coordinated policy and significant investment in workforce talent are urgently needed in the UK.

Share Your Perspective on the Commissioner’s National Priority Vouchers Program

November 14, 2025

Take our survey to voice your opinions on the bio/pharma industry impacts of the FDA Commissioner’s National Priority Vouchers program.

BBB-Crossing Tech for Lysosomal Storage Disorders at Center of Chiesi–Aliada Partnership

November 13, 2025

A worldwide, exclusive license is being granted to develop and commercialize enzyme replacement therapies using proprietary platform technology.

Achieving a Personalized Digital Control Arm for Preclinical Drug Evaluation

November 13, 2025

At AAPS PharmSci 360 2025, Elly Zhou says digital twins helped forecast the effects of drugs on human drugs via a digital control arm.